FIELD: chemistry.
SUBSTANCE: invention relates to a compound of the following formula (II) or formula (III), or a compound which is one of A7, A9, A10, A12, A15, A20, A21, A22, A23, A24, A27, A30, A31, A32 and A48.In formulas (II) and (III) R1 is selected from -R1’-X, R1’ represents -(CH2)0-6- and X is hydroxyl, C(O)O(CH2)1-3NRaRb, -C(O)NH(CH2)1-3NRaRb, NHC(O)(CH2)1-3NRaRb, -NHC(O)CH(NRaRb)(CH2)1-3NRaRb or 5–6-membered heteroaryl containing 1–3 heteroatoms independently selected from N, wherein said heteroaryl optionally substituted with the following groups: -(CH2)1-3OH, -(CH2)1-3NRaRb and -(CH2)1-3C(O)NRaRb; or X can also be or Ra and Rb are independently selected from H, C1-3-alkyl, -(CH2)1-3NH2 and (CH2)1-3NH(CH2)1-3NH2; or Ra and Rb together with the nitrogen atom to which they are attached form 5–10-membered heterocycle, which includes 1–3 heteroatoms selected from N or O, wherein said heterocycle is optionally substituted with C1-6alkylhydroxyl; each M is independently selected from C(O)O- or -C(O)NH-; each R' is independently selected from C1-10-alkyl or C3-12-alkenyl; each R* is independently selected from C1-10-alkyl; n and m are independently selected from an integer in range from 1 to 9. Invention also relates to compositions containing said ionisable lipid compound and a method of producing a lipid nanoparticle based thereon.
EFFECT: compounds can be used in compositions for administering pharmaceutical preparations based on nucleic acids, such as mRNA and siRNA.
41 cl, 5 dwg, 10 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | 2018 |
|
RU2798342C2 |
OXIDISED LIPIDS AND THEIR APPLICATION FOR TREATMENT OF INFLAMMATORY DISEASES AND DISTURBANCES | 2004 |
|
RU2362567C2 |
FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | 2018 |
|
RU2808990C2 |
OXIDISED LIPID COMPOUNDS AND THEIR APPLICATION | 2009 |
|
RU2532546C2 |
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | 2017 |
|
RU2759678C2 |
COMPOUNDS BASED ON PLATINUM AND LIPIDS AND NANOPARTICLES | 2014 |
|
RU2737735C2 |
LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES | 2014 |
|
RU2679896C2 |
COMPOUNDS FOR TARGETED DELIVERY OF MEDICINE AND ENHANCED SIPHK ACTIVITY | 2012 |
|
RU2632888C2 |
LIPID NANOPARTICLES FOR IN VIVO MEDICINAL PRODUCTS DELIVERY AND THEIR USE | 2020 |
|
RU2799045C1 |
PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING | 2003 |
|
RU2333210C2 |
Authors
Dates
2024-08-27—Published
2021-05-27—Filed